Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients

Table 4

Cost analysis: summary of the sensitivity analysis—best and worst case.

Total iron dose for patient	Variables	Ferric carboxymaltose	Ferric gluconate; (1 vial per session)	Ferric gluconate; (2 vials per session)
1000 Mg	Administration time (hours)	0.41–0.58	14.72–38.72	7.36–19.36
	Labor cost (€)	24.34–28.70	405.49–1017.47	216.56–522.55
	Medication and; instrumentation costs (€)	86.07–271.91	34.38–45.9	23.01–34.53
	Total costs (€)	110.41–300.61	439.87–1.063.31	239.57–557.08
	Regional reimbursement (€)	108.91	80.66	56.66
	Reimbursement cost (€); Variation best-worst case	−1.50–−191.70	−359.21–−982.65	−182.91–−500.42
500 Mg	Administration time (hours)	0.41–0.58	7.36–19.36	3.68–9.68
	Labor cost (€)	24.34–28.70	216.56–522.55	122.10 –275.09
	Medication and; instrumentation costs (€)	43.44–136.36	26.54–33.26	15.17–21.89
	Total costs (€)	67.78–165.64	233.75–545.50	133.61–292.36
	Regional reimbursement (€)	66.29	56.66	44.66
	Reimbursement cost (€); Variation best-worst case	−1.49–−99.35	−177.09–−488.84	−88.95–−247.70